For the Inventor, By the Inventor

Enter assignee name

Taro Pharmaceutical Industries Limited

USPTO Granted Patents = 38

% Expired Patents = 39.5

EPO Patents = 5

Trademarks = 3

Forward Citations = 310

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Daniella Gutman (7 out of 23 patents)

Avi Avramoff (6 out of 15 patents)

Daniel A Moros (6 out of 28 patents)

4. Ron Schlinger (5 out of 11 patents)

5. Helena Shifrin (5 out of 12 patents)

6. Tzviel Sheskin (5 out of 6 patents)

7. Avraham Yacobi (5 out of 17 patents)

8. Barrie Levitt (5 out of 10 patents)

9. Rosa L Cyjon (5 out of 17 patents)

10. Vered Rosenberger (4 out of 5 patents)

11. Irena Oleinik (4 out of 4 patents)

12. Sorin Bercovici (4 out of 4 patents)

13. Dan Moros (4 out of 5 patents)

14. Daniela Gutman (3 out of 4 patents)

15. Hershel Herzog (3 out of 4 patents)

Core Competencies:

Montelukast

Trifarotene

Capecitabine

Barbituric Acid

Ondansetron

Warfarin

Keratolytic Agents

Carbamazepine

Oxopyrimidine

Antifungal

Controlled Delivery

Pharmaceutical Compositions

38 patents: Sort by Forward Citations

1. 12233055 - Topical Montelukast formulations (2025-02-25),

2. 11844861 - Topical Montelukast formulations (2023-12-19),

3. 11691946 - Preparation of Trifarotene and intermediates and polymorphs thereof (2023-07-04),

4. 11559541 - Topical capecitabine for the treatment of hyperproliferative skin conditions (2023-01-24),

5. 11173117 - Topical Montelukast formulations (2021-11-16),

6. 10548837 - Topical montelukast for treatment of atopic dermatitis (2020-02-04),

7. 10112970 - Process for the preparation of 17-desoxy-corticosteroids (2018-10-30),

8. 9334219 - Process for the preparation of a stable polymorphic form of Atovaquone (2016-05-10),

9. 9233898 - Process for the preparation of 2-phenyl-1,3-propanediol (2016-01-12),

10. 8314115 - Method of treating movement disorders using barbituric acid derivatives (2012-11-20),

11. 8158639 - Non-sedating barbiturate compounds as neuroprotective agents (2012-04-17),

12. 7776871 - Method of treating movement disorders using barbituric acid derivatives (2010-08-17),

13. 7723346 - Non-sedating barbiturate compounds as neuroprotective agents (2010-05-25),

14. 7696356 - Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom (2010-04-13),

15. 7683162 - Process of preparing a crystalline azithromycin monohydrate (2010-03-23),

Company Overview

Taro Pharmaceutical Industries Limited is a global pharmaceutical company headquartered in Haifa, Israel. The company specializes in the development, manufacturing, and marketing of a diverse range of generic and specialty pharmaceuticals. Taro focuses on various therapeutic areas, including dermatology, cardiology, and psychiatry, leveraging advanced research and development capabilities to deliver high-quality products. With a commitment to innovation and regulatory compliance, Taro aims to enhance patient care and improve health outcomes worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

38 Patents

#9 in Haifa

#144 in Israel

#17,860 in the World

Taro Pharmaceutical Industries Limited

Forward Citations = 310

54 inventors:

Daniella Gutman (7 out of 23 patents)

Avi Avramoff (6 out of 15 patents)

Daniel A Moros (6 out of 28 patents)

4. Ron Schlinger (5 out of 11 patents)

5. Helena Shifrin (5 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Taro Pharmaceutical Industries Limited. Retrieved from https://idiyas.com/company/taro-pharmaceutical-industries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…